Testing effectiveness (Phase 2)Ended earlyNCT04826432
What this trial is testing
Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis
Who this might be right for
Peritoneal Carcinomatosis
Gustave Roussy, Cancer Campus, Grand Paris 6